TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load.

Michael Dougan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.